Demis Hassabis, co-founder of Google DeepMind, is stepping back from daily CEO duties to concentrate on advancing artificial general intelligence (AGI), scientific research, and his AI drug discovery startup, Isomorphic Labs. This leadership change reflects the tension between Hassabis' long-term scientific ambitions and Google's urgent need to commercialize AI technology amid fierce competition from rivals like OpenAI and Anthropic. Hassabis believes AGI is near and aims to balance responsible AI development with the pressure to scale and monetize AI products quickly. The move signals a strategic shift to integrate DeepMind's scientific goals with Google's broader AI commercialization efforts.
Alphabet Inc.'s stock has surged 79% since July 2025, fueled by its acquisition of Wiz and a strategic shift to multi-cloud security. The company's Google Cloud Platform (GCP) growth is driven by AI-powered security features, adoption of the Gemini A...
Broadcom is building its AI business by co-designing custom chips and networking solutions for major hyperscalers under long-term contracts, unlike Nvidia which sells GPUs broadly. This approach has secured multi-year deals with companies like Google...
Google introduced the Fitbit Edge, a new wearable priced at $179.99, positioned between the Fitbit Air and Pixel Watch. It features a slim band with an OLED display for maps, notifications, weather, and music controls. The device supports Google Heal...
The Fidelity Blue Chip Growth ETF (FBCG) has been upgraded to a BUY rating due to renewed momentum in AI-related blue chip stocks and attractive valuations compared to the Russell 1000 Growth index. The ETF's portfolio is heavily concentrated, with 5...
Ray Dalio cautions that stocks have limited room for error as rising bond yields narrow the advantage of equities over bonds. He highlights that AI companies are burning cash rapidly, creating liquidity challenges despite strong earnings, with some f...
